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Abstract: Frog virus 3 (FV3) is the best characterized member of the family Iridoviridae. 
FV3 study has provided insights into the replication of other family members, and has 
served as a model of viral transcription, genome replication, and virus-mediated  
host-shutoff. Although the broad outlines of FV3 replication have been elucidated, the 
precise roles of most viral proteins remain unknown. Current studies using knock down 
(KD) mediated by antisense morpholino oligonucleotides (asMO) and small, interfering 
RNAs (siRNA), knock out (KO) following replacement of the targeted gene with a 
selectable marker by homologous recombination, ectopic viral gene expression, and 
recombinant viral proteins have enabled researchers to systematically ascertain replicative- 
and virulence-related gene functions.  In addition, the application of molecular tools to 
ecological studies is providing novel ways for field biologists to identify potential 
pathogens, quantify infections, and trace the evolution of ecologically important viral 
species. In this review, we summarize current studies using not only FV3, but also other 
iridoviruses infecting ectotherms. As described below, general principles ascertained using 
FV3 served as a model for the family, and studies utilizing other ranaviruses and 
megalocytiviruses have confirmed and extended our understanding of iridovirus 
replication. Collectively, these and future efforts will elucidate molecular events in viral 
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replication, intrinsic and extrinsic factors that contribute to disease outbreaks, and the role 
of the host immune system in protection from disease. 
Keywords:  ranavirus;  Iridoviridae;  virus replication;  viral gene function;  ectothermic 
vertebrates; antisense morpholino oligonucleotides; knock out mutants 
 
1. Taxonomy 
Frog virus 3 (FV3) is the type species of the genus Ranavirus (family Iridoviridae) [1-3]. The genus 
Ranavirus is one of five genera within the family: members of the Ranavirus, Megalocytivirus, and 
Lymphocystivirus  genera infect cold-blooded vertebrates (amphibians, reptiles and bony fish,  
i.e., superclass Osteichthyes), whereas members of the remaining two genera (Iridovirus  and 
Chloriridovirus) infect invertebrates, e.g., insects and crustaceans.  The family Iridoviridae  is 
phylogenetically linked to several other families of nuclear, cytoplasmic, large, DNA-containing 
viruses (NCLDV) such as Phycodnaviridae,  Poxviridae,  Asfaviridae,  Ascoviridae, and   
Mimiviridae [4-7]. Because one of the genus designations (Iridovirus) is a variation of the family 
name, viruses within the family are generically referred to as iridovirids.  
Iridovirids are large dsDNA containing viruses whose virions display icosahedral symmetry [3]. 
Virions range in size from 120–200 nm in diameter, although viruses within the genus 
Lymphocystivirus may be as large as 300 nm. Consistent with this range of particle sizes, genomes, 
depending upon the virus, vary from 105–212 kbp and encode between 92–211 putative proteins 
(Table 1). Genomes of those viruses infecting fish (Lymphocystis disease virus, LCDV; Singapore 
grouper iridovirus, SGIV; and Epizootic haematopoietic necrosis virus, EHNV; Infectious spleen and 
kidney necrosis virus, ISKNV) are larger than those infecting amphibians and reptiles (FV3,   
soft-shelled turtle iridovirus, STIV; and Ambystoma tigrinum virus, ATV), whereas those infecting 
invertebrates (Invertebrate iridovirus 3, IIV-3; IIV-6, and IIV-9) are larger still. Virus-infected cells 
display morphologically distinct viral assembly sites (VAS) within the cytoplasm and virions are 
readily observed within VAS, paracrystalline arrays, or budding from the plasma membrane.  The 
unique appearance of infected cells is strong presumptive evidence of iridovirid infection although 
additional biochemical and histological studies are needed to determine the precise genus and species 
of the infecting virus.  In addition to different host preferences (i.e.,  vertebrates  vs.  invertebrates), 
ranaviruses, megalocytiviruses, and lymphocystiviruses differ from the other two genera by their high 
level (~25%) of cytosine methylation. Division of the family into two subfamilies (Chordiridovirinae 
and Invertiridovirinae) based on methylation status and host preference is currently being considered. 
However, the observation that some ranaviruses (SGIV) lack a virus-encoded DNA methyltransferase 
gene [8], and that some invertebrate iridoviruses appear to infect reptiles [9,10], suggests caution in 
this regard.  
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Table 1: Sizes and coding potentials of iridovirid genomes. 
Genus  Species
a  Size (bp)  No. ORFs
b  % G+C  GenBank Accession Number 
Iridovirus  IIV-9  206,791   191  31  GQ918152 
  IIV-6  212,482  211  29  AF303741 
           
Chloriridovirus  IIV-3  191,132  126  48  DQ643392 
           
Lymphocystivirus  LCDV-1  102,653  108  29  L63545 
  LCDV-C  186,250  178  27  AY380826 
           
Ranavirus  TFV  105,057  105  55  AF389451 
  ATV  106,332  92  54  AY150217 
  FV3  105,903  97  55  AY548484 
  STIV  105,890  103  55  EU627010 
  EHNV  127,011  100  54  FJ433873 
  SGIV  140,131  139  49  AY521625 
  GIV  139,793  139  49  AY666015 
           
Megalocytivirus  ISKNV  111,362  117  55  AF371960 
  RBIV  112,080  116  53  AY532606 
  RSIV  112,414  93  53  BD143114 
  OSGIV  112,636  116  54  AY894343 
  TRBIV  110,104  115  55  GO273492 
a IIV-9, Invertebrate iridovirus type 9 (Wiseana iridovirus); IIV-6, Invertebrate iridovirus type 6 
(Chilo iridovirus); IIV-3,  Invertebrate iridovirus type 3  (mosquito  choriridovirus); LCDV-1, 
Lymphocystis disease virus 1; LCDV-C, Lymphocystis disease virus - China; TFV, tiger frog virus; 
ATV, Ambystoma tigrinum virus; FV3, Frog virus 3; STIV, soft-shelled turtle iridovirus; EHNV, 
Epizootic haematopoietic necrosis virus;  SGIV, Singapore grouper iridovirus; GIV, grouper 
iridovirus; ISKNV, Infectious spleen and kidney necrosis virus; RBIV, rock bream iridovirus; 
RSIV, red seabream iridovirus; OSGIV, orange spotted grouper iridovirus; TRBIV, turbot reddish 
body iridovirus.  Viral names in italics indicate viral species recognized by the International 
Committee on Taxonomy of Viruses; those in standard type are either unrecognized species or 
isolates of recognized species; synonyms are indicated within parentheses.  
b Number of putative ORFs [11-14]. 
2. Vital Statistics: Virion Structure and Genomic Organization 
2.1. Virion Morphology and Composition  
Aside from differences in virion and genome sizes, the organization of virus particles within the 
family is generally similar. While transmission electron microscopy (TEM) has been conducted using 
FV3 and other iridovirids, detailed cryo-electron microscopic (CryoEM) analyses (discussed below) 
were performed with IIV-6 and provide the most detailed view of virion structure. Virions exist in two 
forms: non-enveloped particles ~120–180 nm in diameter, and enveloped particles that acquire an 
envelope by budding from the plasma membrane. In addition to the external envelope, some iridovirids Viruses 2011, 3                      
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contain a fringe of fine fibers (fibrils) that extend outward from the capsid subunits [15,16].  
Non-enveloped particles are composed of three distinct layers: an outer capsid composed of multiple 
copies of an ~50 kDa major capsid protein (MCP), an internal lipid membrane possibly derived from 
the endoplasmic reticulum (ER) or other cellular membranes, and an inner core containing the viral 
genome and associated virus-encoded proteins [16,17].  The MCP shows marked sequence 
conservation within all members of the family [18]. Sequence identity within the MCP gene allows 
primer-based PCR amplification of viral DNA and provides an easy way to determine whether a given 
virus is a member of the family and to which genera it belongs [19]. Although the MCP is the primary 
structural protein and comprises 40% of the total virion protein content, an additional 36 proteins have 
been identified following gel analysis of purified virions [3]. While many of these proteins likely 
represent virus-encoded catalytic proteins that play various roles in replication, three minor capsid 
proteins have been identified by CryoEM analysis of IIV-6 and designated as finger, zip, and anchor 
proteins [17]. Finger and zip proteins were suggested to stabilize the virus by acting as intercapsomer 
cross-links, whereas the anchor proteins appear to be transmembrane proteins that extend into the 
internal lipid membrane and provide further stabilization. In addition to these proteins, a fifth protein, a 
putative myristoylated protein (FV3 ORF 53R), has been suggested to interact with cellular membrane 
fragments and play a role in virion assembly [20].  
2.2. Genomic Organization  
As shown in Table 1, iridovirid genomes range in size from 105–212 kbp. Ranavirus genomes 
occupy the low end of this range and fall into three groups: the genomes of FV3, ATV, TFV, and 
STIV are 105–106 kbp, EHNV is 127 kbp, whereas SGIV and GIV, likely isolates of the same viral 
species, are 140 kbp in size. Consistent with their sizes, ranaviruses contain between 92 and 139  
close-packed, predominantly non-overlapping ORFs of 50 amino acids or greater [3,11-13]. Repetitive 
regions are common and may explain the high rate of recombination seen within these viruses. In 
addition, a small number of putative microRNAs of unknown function have been detected [21]. Amino 
acid conservation is marked among iridovirid genes, but gene order, even within members of the same 
genus, is not conserved suggesting that expression is likely determined by individual promoter 
elements closely associated with each gene.  Moreover, although viral genes  are expressed in an 
ordered temporal cascade (consisting of immediate early (IE), delayed early (DE), and late (L) genes) 
nucleotide sequences corresponding to IE, DE, and L promoters have not yet been identified. The 
observation that gene order is not conserved supports the view that genes can be reshuffled through 
recombination without adversely affecting expression. Microarray analysis suggests that FV3 contains 
33 IE, 22 DE, and 36 L genes [22]. Moreover, the classes assigned in that study were generally similar 
to those assigned to known SGIV genes in two earlier studies [23,24]. Although all ranaviruses contain 
a core set of 72 genes [11], unique genes are found within specific viral species.  Genes held in 
common (e.g., viral DNA polymerase, MCP, the large and small subunits of the viral RNA 
transcriptase, etc.) are thought to be those required for replication in all cell types, whereas those 
unique to a given viral species may represent specific host adaptations that contribute to virulence, host 
range, and immune evasion.  Viruses 2011, 3                      
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3. Viral Replication Strategy 
Early studies of iridovirid replication were conducted almost exclusively using FV3, whereas recent 
studies have included additional ranaviruses such as ATV and SGIV and several megalocytivirus 
isolates that have been linked to massive die-offs in mariculture facilities in Japan and south-east Asia. 
Below we summarize events in FV3-infected cells and highlight recent work that has appeared since 
the last comprehensive reviews [1,2,15,25]. 
3.1. Virion Entry  
FV3 virions, and presumably virions of all other iridoviruses, exist in two forms: non-enveloped 
(i.e., naked) particles and enveloped virions. Although both forms are infectious, enveloped virions 
were shown to have higher specific infectivity [26,27]. With regard to entry, enveloped particles likely 
enter cells by receptor-mediated endocytosis in a pH-dependent manner and require clathrin-coated 
pits, whereas naked particles enter by fusion at the plasma membrane [26,28]. Recently this model has 
been questioned by Guo and co-workers who argued that tiger frog virus (TFV), a ranavirus nearly 
identical to FV3, enters cells by an atypical, pH-dependent, caveola-mediated endocytic pathway [29]. 
Their conclusion was based on experiments using chlorpromazine and over-expression of a   
dominant-negative form of Esp15 that inhibited assembly of clathrin-coated pits, but did not affect 
entry.  Consistent with a role for caveolae, endocytosis of TFV was dependent on membrane 
cholesterol and was blocked by caveolin-1 scaffolding domain protein. Given that FV3 and TFV are 
nearly identical in nucleotide sequence [30,31], it is surprising that their modes of entry are so 
different. Because the reported differences in entry mechanisms between FV3 and TFV may be due to 
infection of cells from different non-physiological hosts, e.g., rats and hamsters, resolution of this issue 
will require direct comparison of TFV and FV3 entry using the above approaches coupled with TEM.  
3.2. Early Events/Nuclear Phase  
Regardless of whether uncoating takes place at the plasma or nuclear membranes, the viral genome 
enters the nucleus.  Unlike herpesviruses, iridovirid genomes are not infectious,  indicating that   
virion-associated proteins are required to initiate viral gene transcription [32].  Accordingly, 
immediate-early (IE) and delayed early (DE) viral transcripts are synthesized in reactions mediated by 
putative virion-associated (for IE transcripts) and virus-encoded (for DE mRNA) transcriptional   
trans-activators and, at least for IE transcription, host RNA polymerase II [33-35]. Among the products 
of early transcription is a viral DNA polymerase which catalyzes the synthesis of unit-sized copies of 
the viral genome within the nucleus [36]. Additional IE and DE proteins include proteins that may play 
roles in blocking host immune responses such as a virus-encoded, CARD (caspase activation and 
recruitment domain) motif-containing  protein  (vCARD),  β-hydroxysteroid  dehydrogenase  (βHSD), 
and a RNAse III-like protein, catalytic proteins involved in nucleic acid synthesis (Proliferating Cell 
Nuclear Antigen [PCNA], DNA methyltransferase [DMTase], the large and small subunits of the viral 
homolog of cellular RNA polymerase II [vPOL-IIα  and  -IIβ],  transcription  factor  IIS),  catalytic 
proteins that may act to increase dTTP pool sizes and influence host  range (deoxyuridine 
triphosphatase [dUTPase], deoxynucleotide kinase, the large and small subunits of ribonucleotide Viruses 2011, 3                      
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reductase), and proteins non-essential for replication in vitro, but needed for growth in vivo (the 18K 
protein) [22].  
3.3. Late Events/Cytoplasmic Phase  
Following its synthesis, unit-sized viral DNA is transported into the cytoplasm where it is 
methylated by a virus-encoded DMTase and, following a second round of DNA synthesis, converted 
into large concatameric molecules that are thought to be the substrate from which viral genomes are 
derived [36-38]. Virion formation takes place in electron-lucent, morphologically-distinct VAS. VAS 
contain viral DNA and the structural and non-structural proteins that give rise to virions, but are devoid 
of ribosomes, mitochondria, and other cellular organelles [39,40]. Although little is known about the 
precise process of virion morphogenesis, by analogy to African swine fever virus and by study of 
various iridovirids, it appears that host membranes, perhaps derived from the ER, serve as a scaffold to 
which capsid and shell proteins bind [41,42]. As progressively larger amounts of viral proteins bind the 
membrane scaffold, crescent-shaped structures that resemble icosahedral vertices are formed. 
Ultimately both full and empty icosahedral virus-like particles are detected. However, it is unclear 
precisely how the genome is encapsidated. While packaging via a headful mechanism explains the 
circularly-permuted terminal redundancy detected within all iridovirids [43], it is not known whether 
nearly complete virions bind viral DNA and internalize it through a virion portal as seen in some viral 
systems  [44-46], or whether developing crescents/icosahedrons engulf the viral genome as they 
assemble.  Following their formation, virions remain  within VAS, accumulate within cytoplasmic 
paracrystalline arrays, or bud from the plasma membrane. At late times after infection, virions are 
sometimes seen within the nucleus and elongated tubular structures can be detected in VAS, but these 
are likely artifacts that reflect breakdown of the nuclear membrane and the disruption of the assembly 
process due to the shortage of key structural proteins and the dysregulation of cellular and viral 
macromolecular synthesis. A transmission electron micrograph of an FV3-infected fathead minnow 
cell is shown in Figure 1A, and an enlargement of the VAS, displaying full and empty virions, is 
shown in Figure 1B.  
The identities of virus-encoded proteins involved in virion assembly remain to be determined. 
Twelve complementation groups defective in the ability to synthesize infectious virions have been 
identified through study of temperature-sensitive (ts) mutants (see below), but it is unclear whether the 
gene products encoded by these 12 complementation groups represent scaffold proteins that are 
required for virion assembly, but which are not incorporated into mature particles, authentic viral 
structural proteins, or virion-associated accessory proteins required for viral replication [47]. Aside 
from the MCP, only FV3 ORF 53R, which encodes a putative myristoylated membrane protein, has 
been linked to virion assembly. Knock down studies using either asMOs or artificial microRNAs 
[20,48] demonstrated that 53R was required for virion assembly, whereas in vitro studies showed 53R 
was associated with virus factories and the virion membrane [49]. By analogy to ASFV, 53R may play 
a role in recruiting ER-derived membranes into virus factories where they serve as precursors of the 
inner viral lipid membrane and/or act as a scaffold protein.  Viruses 2011, 3                      
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Figure 1. Ultrastructural analysis of FV3-infected FHM cells. (A) An FV3-infected cell 
displaying virions budding from the plasma membrane (long arrow) or present within a 
paracrystalline array (short arrow), a viral assembly site (star), and the nucleus (N) 
showing chromatin condensation;  (B)  an enlargement of a viral assembly site (star) 
showing both full and empty virions and possible assembly intermediates. The assembly 
site is surrounded by mitochondria (M) and membraneous structures, possibly elements of 
the endoplasmic reticulum (ER). 
 
 
As with other nuclear and cytoplasmic, large DNA viruses (NCLDV) late viral gene expression is 
dependent upon full viral DNA synthesis, and is catalyzed by a virus-encoded or virus-modified 
transcriptase [47]. Temperature-sensitive mutants defective in viral DNA synthesis show markedly 
reduced levels of late gene expression as do cells treated with drugs (phosphonoacetic acid [PAA], 
cytosine arabinoside [araC]) that block DNA synthesis [50,51].  FV3 and other iridovirids encode 
homologs of the two largest subunits of RNA polymerase II and likely use these proteins, and perhaps 
others, to catalyze late viral gene expression [30]. Knock down of the expression of the largest subunit 
of the viral homolog of RNA polymerase II (i.e., vPOL-IIα) results in a marked reduction in the 
synthesis of late viral proteins and a corresponding reduction in virion formation and supports the 
notion that vPOL-IIα, and other viral proteins, are responsible for late viral gene expression [52]. 
Aside from the MCP, other late proteins tentatively involved in DNA packaging and virion assembly 
include ORF 1R, a putative packaging protein, and EVR1/ALR, a protein involved in the formation of  
disulfide bonds [53]. To illustrate the above, a schematic diagram of the viral replication cycle is 
shown in Figure 2. 
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Figure 2. Life cycle of Frog virus 3 (FV3). The life cycle of FV3 is shown in schematic 
form. See text for details [54]. Used with permission. 
 
3.4. Effect of Virus Infection on Host Functions  
As with other viruses, FV3 infection markedly inhibits host macromolecular synthesis and triggers 
apoptosis [55-58]. Both phenomena are mediated by heat- or UV-inactivated virus indicating that the 
inhibitory agent is a virion-associated protein [58,59]. Viral infection appears to trigger activation of 
PKR, a double-stranded RNA-activated protein kinase, which leads to the phosphorylation of the 
largest subunit of eukaryotic initiation factor 2 (eIF-2α)  and  the  subsequent  inhibition  of  protein 
synthesis [56]. Viral translation may be spared due to the synthesis of large amounts of highly efficient 
viral transcripts and the presence of a virus-encoded protein, e.g., a viral homolog of eIF-2α (vIF-2α), 
that acts as a pseudosubstrate and prevents phosphorylation/inactivation of eIF-2α [57,60-62]. Most 
ranaviruses, with the exception of FV3, contain a full-sized vIF-2α gene [63,64]. However, because the 
absence of a full-sized vIF-2α gene in FV3 does not adversely affect viral protein synthesis, other viral 
proteins may also play roles in maintaining viral protein synthesis in infected cells. 
Aside from the aforementioned vIF-2α protein, FV3 and other ranaviruses encode a number of 
putative immune evasion gene products including βHSD, vCARD, and an RNAse III-like protein. By 
analogy to a similar protein in vaccinia virus, βHSD is thought to trigger glucocorticoid synthesis in 
infected animals and enhance virus replication by suppression of the overall immune response [65,66]. Viruses 2011, 3                      
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Likewise, vCARD may inhibit the induction of interferon and/or apoptosis. Induction of IFN and/or 
apoptosis follows interaction of RIG-I or MDA5, cellular proteins that bind dsRNA, with downstream 
effectors such as MAVS and ISP-1 [67-73]. Since RIG-I/MDA5 and MAVS/ISP-1 interactions are 
mediated by CARD motifs, it is possible that a viral CARD-containing protein might bind either one or 
both of these proteins and short-circuit the IFN induction pathway [74]. The RNAse III-like protein is 
found within all iridoviruses and has been postulated to block siRNA-mediated interference, or to play 
a role in the processing of viral mRNAs [75]. Alternatively, viral RNAse III could act like vaccinia 
virus E3L and bind and/or degrade dsRNA and block the activation of PKR, the induction of 
interferon, and the inhibition of protein synthesis [62].  
As with vaccinia virus [76-78], iridoviruses that infect ectothermic animals encode a series of 
proteins whose function is to ensure an adequate supply of nucleotides for viral DNA synthesis. These 
enzymes include the two subunits of ribonucleotide reductase [79,80], thymidine kinase [30], 
thymidylate synthase, dUTPase [81], purine nucleoside phosphorylase (PNP), and a dihydrofolate 
reductase homolog [12,82]. Not all of these putative enzymes are found within each viral species, and 
it is postulated that specific enzymes might be needed in certain hosts. For example, PNP is found only 
within GIV and it has been suggested that because GIV’s natural host, the grouper, might not be able 
to supply the purine nucleotides required for viral replication the virus encodes its own PNP [82]. 
4. Viral Genomes and Evidence for Host Shifts  
Currently there are seven completely-sequenced ranavirus genomes ranging in size from   
105–140 kbp (Table 1). Whole genome dot plot analyses show that there are three distinct genomic 
organizational profiles among ranaviruses that are based on the conservation of gene order [12]:  
FV3-like viruses (i.e. FV3, TFV and STIV), ATV-like viruses (i.e. ATV and EHNV) and GIV-like 
viruses (i.e.  SGIV and GIV). Dot plot comparisons of viruses within each group show complete   
co-linearity. However, comparison of ATV-like ranaviruses with FV3-like ranaviruses detected two 
large inversions, whereas comparing either of these groups to GIV-like viruses revealed very little 
conservation of gene order [11,83]. In the latter case, gene order is so jumbled between FV3/ATV-like 
viruses and SGIV/GIV-like viruses that any trace of the 45 degree diagonal line, indicative of complete 
sequence alignment between genomes in dot plots, is lost.  Interestingly, ranavirus genomic 
organization is markedly different from that of poxviruses. For example, all members of the subfamily 
Chordopoxvirinae  share a conserved genomic core structure wherein gene order, with the single 
exception of avipoxviruses, is conserved [84]. However, despite the conservation of gene order, global 
sequence alignments show that sequence identity among members of the Chordopoxvirinae is only  
27–29% [85,86]. Ranaviruses, on the other hand, share a much greater sequence identity (~72 – 95% 
within the MCP)  yet have three widely divergent genomic organizations. Moreover, as additional 
ranavirus genomes are sequenced, we may discover novel genomic morphotypes that will elucidate the 
evolutionary relatedness of ranaviruses.  
Examination of complete ranavirus genomic sequences, including whole genome dot plot and 
phylogenetic analyses of ranavirus core genes, suggested that ranaviruses have undergone a number of 
evolutionarily-recent host shifts [12,87].  Phylogenetic analysis using the 26 core iridovirid genes 
identified by Eaton and her co-workers [11] support whole genome dot plot analysis and indicate that Viruses 2011, 3                      
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FV3-like viruses (FV3, TFV, STIV), ATV-like viruses (ATV and EHNV), and GIV-like viruses 
(SGIV and GIV) cluster on separate branches of the ranavirus tree (Figure 3). Collectively, these data 
suggest that for the greater part of their evolutionary history, ranaviruses were restricted to infecting 
fish.  In addition, the shallow branch lengths of FV3-like and ATV-like viruses, which infect 
amphibians and fish, suggest that this group of viruses has recently, at least in evolutionary terms, 
radiated to infect a wide-range of poikilothermic vertebrates [12]. This hypothesis is supported by 
studies showing that ranaviruses are multi-host pathogens [88].  As additional ranaviruses are 
sequenced, particularly those isolates that infect multiple host species, a better understanding of 
ranavirus evolution, host shifts, and the molecular determinants of ranavirus host range and 
pathogenesis will be achieved.  
Figure 3.  Phylogenetic analysis of iridovirus genomes.  A concatenated iridovirus 
phylogeny using 26 conserved open reading frames from completely sequenced members 
of the family Iridoviridae. The tree was created using Mega4 with the Neighbor-Joining 
method, bootstrap (500 replicates) and pairwise deletion options [89]. Members of the 
genus Ranavirus are highlighted in red.  
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5. Pathological and Immunological Aspects of RV Infection 
Pathological and immunological aspects of infection by FV3 and various iridovirids will be dealt 
with by Chen and Robert [90] and Miller et al. [91] in this special issue of Viruses. Thus, only a brief 
overview of this topic will be provided here. Although iridovirids, in contrast to the chytrid fungus 
Batrachochytrium dendrobatidis (Bd), have not been reported to drive species extinction, FV3-like Viruses 2011, 3                      
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viruses have caused deaths in several amphibian culture facilities and in nature, and megalocytiviruses 
have triggered wide-spread mortality in mariculture operations in   
south-east Asia [1,2,92-95]. Ranavirus infections range from inapparent to fulminant and involve a 
variety of tissues including the skin, kidney, liver, and intestine [96]. Using Xenopus laevis as a model 
host, Robert and his colleagues have shown that FV3 infection occurs in both larval and adult   
animals [96-102]. However, whereas infections of immunocompetent adult frogs are confined to the 
kidney and cleared within a few weeks, infection of tadpoles or immunocompromised adults results in 
widespread infection that spreads to multiple internal organs and often leads to death. Protection from 
FV3 infection appears to involve both humoral and cell-mediated immunity and both antiviral 
antibodies and cytotoxic T cells have been identified as protective. Vaccination may prove useful in 
protecting susceptible species and vaccines have been developed to protect commercially important 
fish from megalocytivirus infection [103,104].  Likewise, infection of bullfrog tadpoles (Rana 
catesbeiana) with less pathogenic FV3 protected them against death following infection with the more 
pathogenic Rana catesbeiana virus Z [63].  
6. Ecology of Iridovirus Infections 
As with the above section, the ecology of ranavirus infections will be more fully discussed by 
Miller and co-workers in their contribution to this issue [91]. Suffice it to say iridovirus infections have 
a marked effect on lower vertebrates. As Green and co-workers observed most mortality events seen 
among amphibians from 1996–2001 were attributable to iridovirus infections [105].  In addition, 
whereas lymphocystivirus and megalocytivirus infections have, to date, only been detected in fish 
species, ranavirus infections affect three classes of ectothermic vertebrates: bony fish, amphibians, and 
reptiles [2]. Results from experimental challenges as well as natural infections suggest that ranaviruses 
isolated from one species can not only infect different host species within the same genus, but also host 
species from different genera, orders, and classes. For example, amphibian ranaviruses such as Bohle 
iridovirus, FV3, and ATV infect a variety of fish and amphibian species, and at least one insect virus 
appears to also infect reptiles [9,10,88,106-109].  
7. Elucidation of Viral Gene Function 
7.1. Early Studies: Temperature-Sensitive (ts) Mutants and Biochemical Studies 
Early studies with FV3 attempted to elucidate viral replicative events and the function of viral gene 
products using a variety  of inhibitors, e.g., cycloheximide to confine viral gene expression to IE 
transcription, α-amanitin to block host RNA polymerase II activity, phosphonacetic acid to block viral 
DNA synthesis, azacytidine to block the methylation of viral DNA, flurophenylalanine to block the 
expression of late viral proteins, elevated temperatures (37 °C) to confine viral gene expression to 
early transcripts and proteins, etc. (reviewed in [110,111]). In addition, panels of ts mutants were 
generated and subsequently characterized [47,112,113]. Ts mutants proved useful in confirming and 
identifying various aspects of the virus life cycle, e.g., the two-stages of viral DNA synthesis [114]. 
Ultimately, 28 ts mutants were organized into 19 complementation groups comprising three classes 
[47]. Class I mutants (12 complementation groups) appeared to contain mutants with defects in virus Viruses 2011, 3                      
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assembly. These mutants synthesized early and late viral proteins and viral DNA, but did not generate 
infectious virions [47]. Recently, TEM analysis suggested that this class could be further sub-divided 
into at least two subclasses, those that failed to assemble icosahedral particles and those that formed 
ostensibly normal, but non-infectious, icosahedral particles at the non-permissive temperature [115]. 
The remaining complementation groups appeared to contain defects in proteins associated with viral 
transcription (Class II) and viral DNA synthesis (Class III). Consistent with an early study suggesting 
that only early viral proteins were required for assembly site formation [116], TEM analysis suggested 
that full viral DNA synthesis was not required for the formation of viral assembly sites as two ts 
mutants that synthesized markedly reduced levels of viral DNA were able to form large VAS, that 
were devoid of viral DNA, most viral proteins, and viral particles [47,115]. However, although ts 
mutants have contributed to our understanding of FV3 replication, it has not been possible to associate 
a given mutant phenotype with a specific viral ORF, and thus link a specific viral protein with its 
function. To address this issue, we have recently developed approaches that target individual viral 
genes and have used them to determine viral gene function by observing changes in phenotype.  
7.2. Knock Down of Viral Gene Expression Using asMOs 
To link specific viral proteins with their functions, viral gene expression was knocked down (KD) 
using antisense morpholino oligonucleotides (asMOs) and gene function was inferred by changes in 
phenotype.  AsMOs are DNA-like  macromolecules, optimally 25 nucleotides in length, whose 
backbone contains morpholine rings instead of deoxyribose rings and non-ionic, phosphorodiamidate 
bonds in place of phosphodiester links [117].  Moreover, because phosphorodiamidate bonds are 
resistant to degradation by cellular nucleases, asMOs are remarkably stable in cell culture [117]. 
Furthermore, in contrast to siRNAs that sometimes trigger off-targeting effects by activating pattern 
recognition receptors such as toll-like receptor 3 (TLR-3), asMOs are not recognized by cellular DNA 
receptors such as TLR-9 or AIM-2 and thus do not induce innate immune responses. asMOs bind 
complimentary sequences within the 5’ non-translated region, or the region immediately surrounding 
the AUG initiation codon, of the targeted mRNA  and are thought to block scanning of the 40S 
ribosome by steric hindrance. In addition, asMOs also block gene expression by inhibiting splicing or 
preventing interaction of regulatory proteins with their specific target sequence [118]. Collectively 
asMOs have been used to block cellular and viral gene expression both in vitro and in vivo [119-121].  
AsMOs have been used to ascertain the function of several FV3 genes including those encoding the 
MCP, vPol-IIα,  an  18  kDa  immediate-early viral gene product (18K), a putative myristoylated 
membrane protein (53R), and two IE proteins of unknown function: a 70 kDa protein designated 32R, 
and 46 kDa protein termed 46K [20,52,122,123]. In an initial proof-of-concept study,   
Sample et al. [52] showed that asMO treatment knocked down MCP expression by greater than 80% 
and resulted in a corresponding drop in the production of infectious virions without any collateral 
adverse effects on the expression of other viral gene products.  Moreover, MCP knock down was 
accompanied by the appearance of atypical elements within VAS suggesting that in the absence of full 
MCP expression aberrant viral structures, perhaps representing altered products of virion assembly, 
were generated. In the same study, KD of vPOL-IIα was shown to result in a marked reduction in the 
synthesis of late viral proteins. This result provided the first formal evidence that viral homologs of Viruses 2011, 3                      
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host RNA polymerase II played a role in the synthesis of late viral transcripts. Lastly, Sample and  
co-workers observed that KD of the 18K IE protein had no observable effect on viral gene expression 
or replication in vitro suggesting that, at least in fathead minnow cells, 18K was not required for the 
production of infectious virions.  Subsequent KD studies of 53R, a putative virus-encoded 
myristoylated membrane protein, 32R, and 46K confirmed an essential role for each of these proteins 
in FV3 biogenesis [20,122]. KD of 53R resulted in the appearance of putative non-encapsidated viral 
DNA cores within VAS and supported the view that 53R plays a major role in capsid formation. KD of 
32R and 46K, two IE proteins, did not affect the synthesis of other viral proteins, but resulted in a 
>80% reduction in  virion formation.  TEM study showed that cells treated with asMOs targeting   
either 32R or 46K formed viral assembly sites, but failed to form virions or recognizable   
assembly intermediates.  
Studies targeting the virus-encoded RNAse III-like protein (ORF 80L), a putative NTPase (ORF 
9L), the largest subunit of ribonucleotide reductase (ORF 38R), a putative viral membrane protein 
(ORF2L), a DNA packaging protein (ORF 1R), a putative serine/threonine kinase (ORF  57R), a 
putative RAD2-like DNA repair protein (ORF 95R), a 129 kDa protein of unknown function (ORF 
41R), and the viral DMTase (ORF 83R) are ongoing and have demonstrated reductions in viral yields 
ranging from 41–92% [123]. However, unlike the first study in which KD of MCP, vPOL-IIα, and 18K 
was confirmed by 1D SDS-polyacrylamide gel electrophoresis, we have been unable to identify 
unambiguously the targeted protein in these latest studies, and thus do not know if the partial 
reductions in virus yields reflect the non-essential nature of the gene product or incomplete KD of the 
targeted protein. To overcome this problem, recombinant viral proteins will be generated and used to 
produce polyclonal antibodies for Western blot and immunofluorescent analyses. Lastly, although 
asMOs can be powerful tools for uncovering viral gene function, their use is potentially limited by the 
nature of some ranavirus mRNAs.  Because many FV3 transcripts possess very short, AU-rich 5'  
non-translated regions, and because sequences surrounding the AUG initiation codon may be 
unfavorable for targeting due to, for example, high AU content or secondary structure, asMO-mediated 
KD approaches may not succeed with all targeted genes. In these cases, siRNA-mediated KD or KO 
approaches, discussed below, provide alternative approaches. Nevertheless, despite these limitations, 
asMOs have provided insight into the roles of several FV3 genes and will continue to be a useful tool 
for elucidating viral gene function in vitro. Together with anti-viral antibodies to confirm knock down 
and identify intracellular locations, these studies will broaden our understanding of the complex story 
of virus-host interactions.  
7.3. Knock Down of Viral Gene Expression Using siRNA  
As an alternative to asMOs, siRNAs have also been used in a limited number of cases to knock 
down iridovirid gene expression [48,122,124,125]. While knock down has been achieved, we observed 
that inhibition of FV3 gene expression only took place if cells were infected at low multiplicities of 
infection,  i.e., <0.1 PFU/cell.  Similar to the situation in some other viral systems, the inverse 
relationship between multiplicity of infection and siRNA knockdown suggests that a virion-associated 
or virus-encoded protein may block siRNA-mediated knockdown by either binding or degrading Viruses 2011, 3                      
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siRNA [126]. To date, expression of FV3 transcripts encoding MCP, DMTase, and vPOL-IIα have 
been knocked down by siRNA and resulted in a marked inhibition of replication.  
7.4. Knock out Approaches to Elucidate Viral Gene Function  
A powerful and potentially more useful approach to elucidate viral gene function involves the 
generation of knock  out (KO) mutants since, in contrast to transient KD triggered by asMOs or 
siRNAs, the phenotypes of KO mutants can be evaluated both in vitro and in vivo. This feature makes 
KO mutants especially useful for identifying viral genes that play roles in immune evasion and 
virulence. KO mutants have been used extensively to elucidate the function of various poxviruses 
genes [127-129], and methodology developed here has been adapted to ranaviruses. However, despite 
using poxviruses as a guide, ranavirus KO mutants, using homologous recombination to replace the 
targeted gene with a selectable marker, have only recently been isolated. The reasons for the difficulty 
in applying this approach to ranaviruses are not clear, but may reflect the presence of a   
ranavirus-encoded endonuclease that cleaves unmethylated DNA [30,38]. If correct, introduction of 
unmethylated plasmid DNA, bearing the selectable marker, into a virus-infected cell may lead to 
degradation of the majority of plasmid DNA and make recombination unlikely.  As was done 
previously in a recombinant BIV vector [130,131], positioning the selectable marker, e.g., the 
neomycin-resistance gene, downstream of the promoter for the 18K immediate early (IE) gene drove 
high levels of expression of the resistance gene and permitted isolation of rare recombinants.  
The first ranavirus KO mutant targeted the ATV-encoded homolog of eukaryotic translational 
initiation factor 2α (vIF-2α) [132]. As discussed above, following virus infection, host cells activate 
PKR, an interferon (IFN) inducible double-stranded RNA activated protein kinase [133], that, in turn, 
phosphorylates  the  α  subunit  of  eIF-2 and, as a consequence, inhibits both host and viral protein 
synthesis. To prevent translational shut-off, several viruses, including most ranaviruses, encode an  
eIF-2α homolog that has been proposed to function as a pseudosubstrate for PKR [134]. In vaccinia 
virus this homolog is designated K3L, whereas in ranaviruses it is termed vIF-2α. Although K3L and 
vIF-2α differ markedly in size, they share a common sequence motif (VDRVDREKGYVDL) that is 
likely required for activity.  In this scenario, PKR binds K3L/vIF-2α  instead  of  eIF-2α,  and  as  a 
consequence eIF-2α is not phosphorylated and protein synthesis is maintained. To determine if ATV 
vIF-2α (ORF 57R) is functionally similar to K3L, the ranavirus gene was replaced with a selectable 
marker, the neomycin resistance (NeoR) gene. To generate an ATV KO mutant, NeoR was inserted 
downstream of the ATV 18K IE promoter and this construct was bracketed with sequences identical to 
those in the flanking region of the targeted gene. A PCR product bearing this construct was then 
transfected into BF-2 cells and infected with wild-type (wt) ATV. Recombinant virus was isolated by 
selective growth in the presence of neomycin, and replication of the KO mutant was compared to wt 
virus in vitro and in vivo. The KO mutant, designated ATV∆57R, replicated to titers comparable to that 
of wt ATV in vitro, but had a small plaque phenotype. In addition, ATV∆57R was 8-fold more 
sensitive to IFN than wt ATV. The increased IFN sensitivity of ATV∆57R was correlated with the 
increased phosphorylation of eIF-2α and the lack of PKR degradation. In contrast, wt ATV degraded 
PKR and inhibited cellular eIF-2α phosphorylation. In addition, ATV∆57R was less pathogenic than 
wt ATV following infection of tiger salamanders (Ambystoma tigrinum) indicating that vIF-2α was a Viruses 2011, 3                      
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likely viral virulence/immune evasion protein. Thus the ATV vIF-2α gene is a putative IFN-resistance 
gene that inhibits cellular innate immune responses by degrading PKR and maintaining high levels of 
viral protein synthesis.  
In an effort to improve the KO methodology, Chen et al. [135] recently developed a potentially 
more powerful dual selection method to generate KO mutants within FV3. In this system, the gene of 
interest is replaced, via homologous recombination, with a gene encoding the puromycin-resistance 
gene fused to the gene for Enhanced Green Fluorescent Protein (EGFP). In initial experiments KO 
mutants targeting the truncated vIF-2α protein (FV3-∆vIF-2α) and the 18K IE protein (FV3-∆18K) 
were generated as well as a control, “knock in” mutant in which the puromycin-resistance/EGFP gene 
was inserted into a non-coding portion of the genome. While all three recombinant viruses grew well 
in vitro, the vIF-2α and 18K KO mutants, but not the control “knock in” mutant, showed a 90% drop in 
virus levels in X. laevis tadpoles. These results confirmed the previous observation that the 18K protein 
was not required for replication in vitro [52], and indicate that 18K plays a role, albeit unknown, in 
replication  in vivo.  The finding that the truncated vIF-2α  protein  of  FV3  was  also  required  for 
replication  in vivo  was surprising because the FV3 homolog of vIF-2α  is  missing  the  N-terminal  
two-thirds of this protein, including the region homologous to vaccinia virus K3L and eukaryotic 
translational initiation factor 2α. Inspection of the FV3 nucleotide sequence indicated that FV3 vIF-2α 
is a chimeric protein resulting from deletion and in-frame fusion of a small upstream ORF with the 
larger, downstream vIF-2α ORF. The resulting product contains 10 amino acids from the N-terminus 
of the upstream ORF and the last 65 amino acids of the full-length vIF-2α  protein.  The reduced 
replication of FV3-∆vIF-2α in vivo suggests that the C-terminal end of the FV3 vIF-2α homolog is 
required for full replication in vivo. In addition to the above KO mutants, a recombinant soft-shelled 
turtle iridovirus has recently been constructed that expresses EGFP. EGFP-expressing mutants may 
provide an alternative, simplified strategy for screening antiviral substrates through the visualization 
and quantification of fluorescent virus [136].  
7.5. Assessment of Viral Gene Function by Analysis of Recombinant Viral Proteins  
In contrast to the above studies, a fourth approach for determining viral gene function involves the 
synthesis of recombinant viral proteins and assessment of their functions in vivo and in vitro. Several 
investigators have used this approach and representative examples are discussed below.  
7.5.1. ICP46  
A putative homolog of FV3 ICP46 was identified in SGIV [137]. ICP46 (mol wt 44.1 kDa) is an IE 
gene product that is distributed predominantly within the cytoplasm but is also found within virions. A 
plasmid expressing ICP46 was introduced into grouper embryonic (GP) and fathead minnow cells and 
stably transfected cells were characterized. Over expression of SGIV ICP46 resulted in higher cell 
densities and increased growth of monolayer cultures. SGIV replication was compared in GP cells 
transfected with an empty vector and in GP cells expressing ICP46. SGIV replicated more rapidly and 
reached titers that were 10-fold higher in ICP46 expressing cells than in control cells.  Although 
conserved domains suggestive of function were not detected within ICP46, the authors speculate, 
based on the above results, that ICP46 might encode a protein involved in cell growth control. The Viruses 2011, 3                      
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authors suggested that ICP46, like IE proteins in other viral systems, might control host cell growth by 
regulating the cell cycle, preventing growth arrest, or delaying apoptosis and play a critical role in 
promoting a proliferative environment that enhances virus replication.  
7.5.2. Viral Vascular Endothelial Growth Factor  
ISKNV (genus  Megalocytivirus) ORF 48R encodes a viral protein with marked similarity to 
vascular endothelial growth factor (vVEGF) [138]. Microinjection of a plasmid expressing vVEGF 
into zebrafish one-cell embryos resulted in pericardial edema and dilation of the tail region suggesting 
that vVEGF triggers vascular permeability. Moreover, vVEGF binds and up-regulates the expression 
of FLK-1 and together both proteins likely contribute to the proliferative and highly vascularized 
nature of ISKNV lesions in its natural host, the Chinese mandarin fish. Although these results suggest 
that ISKNV ORF48R plays a vital role in host infection and viral replication, its precise function 
remains unclear. Following Orf virus (family Poxviridae) infection, the vVEGF homolog aids in scab 
formation and wound healing and may enhance transmission since scabs contains substantial amounts 
of infectious virus.  
7.5.3. Histone Binding Protein 
A novel histone-binding protein was identified in SGIV by structural analysis of the ORF 158L 
gene product [139]. X-ray diffraction analysis of recombinant 158L determined the crystal structure at 
a resolution of 2.2 Å, and  revealed that 158L exhibited partial structural resemblance to the   
histone-binding region of anti-silencing factor 1 (Asf1), a histone H3/H4 chaperon. Using recombinant 
158L protein, interaction was demonstrated between 158L and histone H3/H4 complexes and H3 by 
isothermal titration calorimetry.  The authors suggested that 158L may be involved in both the 
regulation and expression of histone H3 and H4 methylation, events which allow the virus to control 
host cell gene expression and facilitate viral replication.  
7.5.4. SGIV 18K 
SGIV ORF 86R encodes a homolog of the FV3 18K immediate early protein. Although KD studies 
using an asMO targeted against 18K [52] and an 18K knock out mutant [135] indicated that expression 
of 18K was not required for replication in either FHM or BHK cells, replication of the 18K KO in 
Xenopus laevis tadpoles was reduced about 10-fold compared to wt virus or a “knock in” mutant. To 
determine the intracellular location of the 18K gene product, Xia et al. [140] generated recombinant 
SGIV 18K protein and used it to produce rabbit anti-18K serum. Immunofluorescent assay showed 
SGIV 18K to be distributed within the cytoplasm adjacent to VAS and nuclei, and Western blotting 
using purified and disrupted virions indicated 18K was a non-envelope  virion-associated protein. 
Transfection of uninfected grouper cells with a vector expressing 18K enhanced cellular growth rates 
and led to an increase in the density of monolayer cultures. Moreover, SGIV replication in cultures 
expressing 18K were about 10-fold higher than in cultures transfected with an empty vector. The 
authors suggest that 18K may be a protein that plays a role in the control of cellular growth and thus 
indirectly enhances SGIV replication. However, because virus yields were expressed as TCID50/mL, it Viruses 2011, 3                      
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was not clear if the increase in SGIV yield reflected higher virus production per cell or simply 
equivalent cellular yields in cultures containing varying numbers of cells.  
7.5.5. vIF-2α  
Rothenburg et al. [61] cloned the vIF-2α gene from Rana catesbeiana virus Z (RCV-Z) into an 
expression vector and examined its function in a yeast-based assay system. Yeast expressing human 
PKR failed to grow due to the toxicity of the PKR protein. However, yeast expressing vIF-2α, or the 
vaccinia virus K3L protein, suppressed the toxic effects of human PKR indicating that vIF-2α was 
functionally equivalent to the vaccinia virus protein. Subsequent work showed that whereas K3L was 
effective only against human PKR, vIF-2α suppressed the toxic effects of both human and zebrafish 
PKR suggesting that PKR antagonists evolved to protect physiologically-relevant/phylogenetically-
related targets.  In addition, a study using vectors expressing the  various domains of vIF-2α,  
i.e., N-terminal, central/helical, and C-terminal, demonstrated that the N-terminal and central/helical 
domains were sufficient for suppressing PKR toxicity.  Collectively, these results provide the first 
formal proof that vIF-2α functions as a virus-encoded PKR antagonist. 
7.5.6. Additional Studies Using Recombinant Iridovirid Proteins 
Recombinant versions of thymidylate synthase (LCDV-China), ERV1 (Rana grylio virus, RGV), 
dUTPase (RGV), RNAse III (RBIV), and LITAF (SGIV) were generated and evaluated for their 
ability to influence cellular growth, enhance virus replication, induce apoptosis, and cleave dsRNA 
[51,75,141,142]. Recombinant thymidylate synthase from LCDV-China was found to promote cell 
cycle progression and produced a transformed phenotype [143].  Antibodies directed against Rana 
gyrlio virus (RGV) ERV1 detected ERV1 expression within the cytoplasm and nucleus, but not within 
VAS; transcript analysis indicated that ERV1 was a late viral gene product [141]. RGV dUTPase was 
determined to be a DE gene product that was localized to the cytoplasm. Ectopic expression did not 
enhance virus replication,  however, its effect on cellular proliferation was not examined [51]. 
Recombinant RNAse III from RBIV cleaved dsRNA, but the salt optimum for cleavage was 
inconsistent with a physiological effect [75]. The authors speculated that RNAse III might play a role 
in the suppression of RNA interference, as has been suggested for other viral dsRNA-binding proteins, 
or could be involved in the processing of viral RNA. Lastly, Huang et al. [142] demonstrated that the 
SGIV homolog of LITAF (lipopolysaccharide-induced TNF-α factor) was a DE viral gene product. 
LITAF was located within the cytoplasm and was associated with mitochondria. When over-expressed 
ectopically, it led to the activation of caspase 3 and the induction of apoptosis. Collectively, ts mutants, 
asMO- and siRNA-mediated knock down, gene knock out, and recombinant protein studies are slowly 
elucidating the function of iridovirid genes and providing a clearer and more complete picture of how 
those genes enhance viral replication and modulate cellular functions.  
8. Future Directions 
Future studies of ranaviruses and other iridoviruses infecting ectothermic animals will focus on the 
following areas: (1) identifying and elucidating the function of replicative genes and those contributing Viruses 2011, 3                      
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to virulence, host range, and immune evasion; (2) understanding the correlates of antiviral immunity in 
an effort to understand the cellular and molecular basis of anti-viral immunity and to protect 
endangered and commercially important species from infection; (3) determining the impact of 
iridovirus infections in nature, defining viral host range, identifying susceptible hosts and reservoir 
species; (4) understanding how intrinsic (e.g., host immune suppression, host MHC repertoire, etc.) 
and extrinsic (e.g., habitat disruption, environmental stress, introduction of invasive species, etc.) 
factors influence the clinical outcomes of iridovirus infection.  For example, determining whether 
iridovirids encode viral immune evasion proteins and how these proteins circumvent host immunity 
will highlight events at the interface of virology and immunology, and may identify possible targets for 
viral attenuation. Successful completion of these studies will involve the interactive efforts of 
virologists, immunologists, population biologists, ecologists, and veterinary pathologists. The Global 
Ranavirus Consortium [144] is but one interactive group of scientists interested in the role of infectious 
agents in population declines. Moreover, it is anticipated that general principles learned through study 
of iridovirus infections will be applicable to the study of other pathogens of cold-blooded vertebrates.  
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